Young Innovators & Early Career Research
Early career research is crucial for science, and in delivering applied microbiology to the world. This page is focused on showcasing innovations and research from early career researchers across the globe and provides a hub for the latest news, opinions, careers advice and research for early career scientists. Discover how interdisciplinary colleagues from around the world are making advancements in, and through, applied microbiology.
News
Source or sink? Trees with heart rot disease emit more methane, upending forest carbon models
New research suggests that upland forests harboring trees with a common and incurable fungal disease known as heart rot could actually be emitting more methane than they take in, therefore releasing more greenhouse gases than previously thought.
Read story
NewsScientists uncover mechanism used by three bacteria-killing viruses to target transporter
Biochemists have homed in on an underexplored small transporter called MurJ that is a vital part of the pathway bacteria use to build their chain-mail-like cell wall. Using advanced tools, the scientists have determined the common mechanism used by three different bacteria-killing viruses to block MurJ from doing its job.
NewsCOVID-19 infection predicts higher risk of kidney disease, study finds
Researchers have found that previous COVID-19 infection is a significant risk factor for kidney disease. Compared to influenza, those with a history of COVID-19 infection have a 2.3-times higher risk of acute kidney injury and a 1.4-times higher risk of chronic kidney disease, according to an analysis of over three million patients.
NewsEmerging class of antibiotics to tackle global tuberculosis crisis
Researchers investigated how three naturally occurring antibiotic compounds – ecumicin, ilamycin and cyclomarin – act on a vital protein degradation machine inside Mycobacterium tuberculosis, the bacterium that causes TB.
More Early Career Research
News
Study finds no evidence of persistent tick-borne infection in people who link chronic illness to ticks
When researchers studied Norwegians who thought tick bites caused their chronic health problems, they found no objective evidence linking the symptoms to ticks. The same study finds that health problems reported by participants were associated with little physical activity and low labour force participation.
NewsStudying yeast in the gut could lead to new, better drugs
A new study sheds light on the behavior of yeast cells in the gut, paving the way for new lines of yeast that more efficiently produce therapeutic drugs tailored to address specific diseases.
NewsThree women named Britain’s Brightest Young Scientists, each winning ‘unrestricted’ £100,000 Blavatnik Awards prize
The Blavatnik Family Foundation and The New York Academy of Sciences has announced the three 2026 Laureates of the Blavatnik Awards for Young Scientists in the United Kingdom, who each receive £100,000 – the nation’s largest unrestricted prize for science.
NewsNew strategies aim at HIV’s last strongholds
A new study has overcome a long-standing challenge—how to isolate and study elusive HIV-infected cells called authentic reservoir clones (ARCs) that evade the immune system, making the disease difficult to cure.
NewsScientists unlock magnetic secrets of bacteria with built-in compass
Some bacteria are miniature masters of navigation: A built-in “compass” made of magnetic nanoparticles helps them to reliably find the optimal habitat. Researchers have now unlocked the magnetic properties of individual bacteria — an important step toward harnessing the potential for technology.
NewsHealthier, tastier kelp: food scientists boost nutrition and flavour of kombu
A team of food scientists has found a way to unlock the trapped nutrients in the edible seaweed, kombu, and replace the strong odours with more appealing scents, directly overcoming the two major challenges – limited nutrient bioaccessibility and poor sensory experience.
NewsFirst evidence of fungal pathogen becoming more deadly when co-infected with tuberculosis
Co-infection of Mycobacterium tuberculosis, together with Cryptococcus neoformans, is a grave public health concern, increasing the risk of death significantly. Researchers have found that in the presence of Mycobacteria, the fungus changed its cell density, cell diversity, and capsule size.
NewsBiocodex Microbiota Foundation announces open call for projects for $50,000 2026 USA Microbiome Research Grant
The Biocodex Microbiota Foundation, an independent organization founded by Biocodex, has opened applications for its 2026 USA research grant. The $50,000 grant will be awarded to a U.S.-based investigator studying the gut microbiota and its relationship to human health and disease.
NewsHoly Grail: One vaccine may provide broad protection against many respiratory infections and allergens
In a new study in mice, researchers have developed a universal vaccine formula that protects against a wide range of respiratory viruses, bacteria and even allergens.
NewsNew review points to faster, safer vaccine development
A new review examines viral mimic systems that reproduce key features of dangerous pathogens such as SARS-CoV-2, the virus that causes Covid-19, without the ability to replicate or cause disease. These systems allow researchers to study infection safely, quickly, and in a wider range of laboratories.
NewsResearchers discover how tuberculosis bacteria use a “stealth” mechanism to evade the immune system
New research reveals that mycobacteria release tiny packages called extracellular vesicles that fuse with the membranes of immune cells. These vesicles contain specialized lipids—fatty molecules—that make the cell membrane more rigid.
NewsPrenatal infection increases risk of heavy drinking later in life
Exposure to infection and other immune stress in the womb increases the likelihood of alcohol misuse in adulthood, a risk that may be reduced through prenatal antioxidant treatment, a new study shows.
NewsMissing microbes in UK infant gut and probiotics highlighted by global microbiome atlas
A global atlas mapping two key gut bacteria in infants around the world has uncovered a treasure trove of bacterial strains adapted to the infant gut and not found in commercial probiotic products. It lays the foundation for more effective, tailored infant probiotics.
NewsInvasive death cap mushrooms are changing their chemistry
Scientists have just published new research about the chemistry of death cap mushrooms (Amanita phalloides) - the species is not only spreading rapidly as an invasive fungal species in the United States, but the move across continents has changed the chemistry of the species.
NewsNovel vaccine protects against C. diff disease and recurrence
A novel vaccination approach cleared the harmful gut bacterium Clostridioides difficile in an animal model of infection. An experimental vaccine administered to the mucosal lining of the colon protected against illness, death, tissue damage and infection recurrence.
NewsMacrophage immune cells need constant reminders to retain memories of prior infections
Researchers have discovered that immune cells known as macrophages remain poised to fight repeat infections due to the persistent presence of signaling molecules left behind during previous infections.
NewsHow bacteria may promote breast cancer
Researchers have discovered how certain pathogenic bacteria in gut and breast tissue can promote breast cancer development and progression by hijacking a key metabolic enzyme known as spermine oxidase (SMOX).
NewsScientists develop first-of-its-kind antibody to block Epstein Barr virus
Using mice with human antibody genes, scientists have developed new genetically human monoclonal antibodies that prevent two key antigens on the surface of the Epstein Barr virus (EBV) from binding to and entering human immune cells.
CareersSummer Studentship: novel antivirals and host-virus interactions
Jessica Harris reports back on her Summer Studentship at De Montfort University, and her research into how plant-derived compounds affect viruses, and whether combining these antivirals might increase viral inhibition.